Rosenberg Mordechai 4

What Happened

• Director Mordechai Rosenberg was reported on a Form 4 as receiving a grant/award of derivative securities covering 250,000 shares of Hyperscale Data (GPUS). The filing shows an acquisition of 250,000 derivative securities at $0.00 (no cash paid).
• Per the filing footnote, the options were originally granted July 31, 2025; 50% of the grant (125,000 options) vested and became exercisable on May 6, 2026 after stockholder and NYSE American approvals. The remaining 50% (125,000 options) vest in equal monthly increments over 24 months beginning June 1, 2026. The options were issued outside any issuer stock incentive plan.
• This was a vesting/award event (not an exercise or sale) — no shares were sold and no cash proceeds were reported.

Key Details

• Transaction date: May 6, 2026 (reported on Form 4 filed May 8, 2026 — timely filing).
• Reported derivative securities: 250,000 options; vested portion on May 6, 2026 = 125,000 options; remaining 125,000 vest monthly over 24 months starting June 1, 2026.
• Reported price: $0.00 (grant/award — no cash paid). Exercise price (strike) is not disclosed in the filing.
• Shares owned after transaction: not specified in the provided filing details.
• Notable footnote: approvals from stockholders (Apr 10, 2026) and NYSE American (May 6, 2026) triggered the vesting; options issued outside any issuer stock incentive plan.

Context

• This is a derivative/vesting event (options became exercisable), not an exercise or open-market purchase. Because the options were not exercised or sold, there was no immediate change in share count outstanding or cash flow from the insider.
• Grants issued outside formal plans and routine vesting are common forms of executive/director compensation; they do not by themselves indicate buying or selling sentiment.